Cited by 1,252Cell death mechanisms and regulationT-cell and B-cell ImmunologyCancer-related Molecular Pathways

BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death.

Open access
Hockenbery, D M, Zutter, M, Hickey, W, Nahm, M, Korsmeyer, S J·1991·Proceedings of the National Academy of Sciences

Abstract

The BCL2 protooncogene encodes an inner mitochondrial membrane protein that blocks programmed cell death. BCL2 was isolated from the chromosomal breakpoint of follicular B-cell lymphoma. Transgenic mice that overexpress BCL2 display extended survival of resting B cells. In this study we use a monospecific anti-human BCL2 antibody to define the distribution of BCL2 protein within organized tissues. BCL2 is restricted within germinal centers to the follicular mantle and to portions of the light zone implicated in the selection and maintenance of plasma cells and memory B cells. BCL2 is present in the surviving T cells in the thymic medulla. All hematopoietic lineages that derive from a renewing stem cell also display BCL2. A limited number of nonlymphoid tissues demonstrate BCL2 and can be grouped as (i) glandular epithelium in which hormones or growth factors regulate hyperplasia and involution, (ii) complex differentiating epithelium such as skin and intestine characterized by long-lived stem cells, and (iii) long-lived postmitotic cells such as neurons. Within these tissues that demonstrate apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones. BCL2's function as an antidote to apoptosis may confer longevity to progenitor and effector cells in these tissues.

AI snapshot

Written from the paper’s full text.

TL;DR

Using a monospecific anti-human BCL2 antibody, the authors map BCL2 protein across organized tissues and find it topographically restricted to long-lived or proliferating zones in tissues with apoptotic turnover. BCL2 is present in selected lymphoid, hematopoietic, glandular epithelial, complex epithelial, and postmitotic neuronal compartments.

Key findings

  • Within germinal centers, BCL2 is restricted to the follicular mantle and portions of the light zone implicated in selection and maintenance of plasma cells and memory B cells.
  • BCL2 is present in surviving T cells in the thymic medulla and in all hematopoietic lineages derived from a renewing stem cell.
  • A limited set of nonlymphoid tissues shows BCL2: glandular epithelium regulated by hormones/growth factors, complex differentiating epithelium such as skin and intestine with long-lived stem cells, and long-lived postmitotic cells such as neurons.
  • In tissues with apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones; the authors suggest BCL2 may confer longevity to progenitor and effector cells.

Methods

  • The study uses a monospecific anti-human BCL2 antibody to define BCL2 protein distribution within organized tissues.
  • The provided text does not report sample sizes, tissue sources, staining protocols, or quantitative analysis details.

Limitations

  • The paper’s abstract does not state limitations.
  • Evident from the provided text: only the abstract and reference list are available, so sample composition, antibody specificity controls, quantification, and full results cannot be assessed. No quantitative values are reported in the provided text.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1073/pnas.88.16.6961

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

0 of 2 cited sources checked · 0 supported · 0 flagged

  • Findingnone given
    § Abstract

    All hematopoietic lineages that derive from a renewing stem cell also display BCL2.

    “All hematopoietic lineages that derive from a renewing stem cell also display BCL2.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
  • Findingown data
    § Abstract

    BCL2 protein is present in the surviving T cells in the thymic medulla.

    “BCL2 is present in the surviving T cells in the thymic medulla.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
  • Findingown data
    § Abstract

    A limited number of nonlymphoid tissues demonstrate BCL2.

    “A limited number of nonlymphoid tissues demonstrate BCL2”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
  • Findingown data
    § Abstract

    BCL2 protein is restricted within germinal centers to the follicular mantle and to portions of the light zone implicated in the selection and maintenance of plasma cells and memory B cells.

    “BCL2 is restricted within germinal centers to the follicular mantle and to portions of the light zone implicated in the selection and maintenance of plasma cells and memory B cells.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
  • Findingown data
    § Abstract

    Within tissues that demonstrate apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones.

    “Within these tissues that demonstrate apoptotic cell turnover, BCL2 is often topographically restricted to long-lived or proliferating cell zones.”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The anti-human BCL2 antibody used in this study is monospecific for BCL2.
  • May combine two claims. 1
  • May combine two claims.

    Premisecitation
    § Abstract

    The BCL2 protooncogene encodes an inner mitochondrial membrane protein that blocks programmed cell death.

    “The BCL2 protooncogene encodes an inner mitochondrial membrane protein that blocks programmed cell death.”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Hockenbery et al., 1990 source
1 of 1
  • The paper relies on this without support.

    The anti-human BCL2 antibody used in this study is monospecific for BCL2.

    “we use a monospecific anti-human BCL2 antibody”
1 of 1

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hockenbery, D. M., Zutter, M., Hickey, W., Nahm, M., & Korsmeyer, S. J.
Affiliations
Washington University in St. Louis (US)
Venue
Proceedings of the National Academy of Sciences
Published
1991-08-15
Volume
88
Issue
16
Pages
6961-6965
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1970629830
Cited by
1,252
References
40
Citations by year
2025: 2 · 2024: 3 · 2023: 9 · 2022: 4 · 2021: 5 · 2020: 10 · 2019: 9 · 2018: 9 · 2017: 9 · 2016: 7 · 2015: 10 · 2014: 15 · 2013: 10 · 2012: 12
FWCI
26.75
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Keywords
Bcl-2, apoptosis, germinal center, light zone, plasma cells, memory B cells, thymic medulla, hematopoietic stem cells, tissue distribution, epithelial stem cells, follicular B-cell lymphoma, transgenic mice
MeSH terms
Adult, Bone Marrow, Breast, Cell Survival, Digestive System, Female, Humans, Immunoenzyme Techniques, Male, Neurons, Pancreas, Prostate, Protein-Tyrosine Kinases, Proto-Oncogene Proteins, Proto-Oncogenes, Skin, Thymus Gland, Palatine Tonsil, Proto-Oncogene Proteins c-bcl-2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-18.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-18.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review